News

Cognitive impairment in HSCT recipients
- Author:
- HT Staff
New research suggests the risk of cognitive impairment after hematopoietic stem cell transplant (HSCT) is greatest among recipients of...
News

AYA cancer patients lost to follow-up
- Author:
- HT Staff
ORLANDO—Many adolescent and young adult (AYA) cancer survivors don’t continue with follow-up care, according to a new study. Researchers analyzed...
News

Intervention helps kids stay active after cancer treatment
- Author:
- HT Staff
ORLANDO—Results of a pilot study suggest a web-based, reward-driven intervention can motivate adolescent cancer survivors to stay physically...
News

Study reveals lack of sexual aids for cancer survivors
- Author:
- HT Staff
ORLANDO—A new study suggests many US cancer centers do not have therapeutic aids for patients who experience sexual dysfunction after cancer...
News

FDA grants ivosidenib NDA priority review
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has accepted for priority review the new drug application (NDA) for ivosidenib, a targeted inhibitor of...
News

NK-cell therapy in resistant MDS, AML
- Author:
- HT Staff
Results of a phase 1/2 trial suggest treatment with haploidentical natural killer (NK) cells can be effective against relapsed/refractory...
News

Team creates device to study hemostasis
- Author:
- HT Staff
Researchers have engineered a miniature model system for studying hemostasis. They believe the device could serve as a drug discovery platform...
News

Drug receives orphan designation for MM
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has granted orphan designation to PT-112 as a treatment for multiple myeloma (MM). PT-112 is a small-...
News

ASCO, NCCN release guidelines on checkpoint inhibitors
- Author:
- HT Staff
Two cancer organizations have released guidelines for managing the side effects of immune checkpoint inhibitors. The American Society of Clinical...
News

Product seems effective for ITI in severe hemophilia A
- Author:
- HT Staff
Results of a retrospective study suggest a recombinant factor VIII Fc fusion protein (rFVIIIFc) can be effective for immune tolerance induction (...
News

Young kids with SCA not receiving recommended prophylaxis
- Author:
- HT Staff
Many young children with sickle cell anemia (SCA) may not be taking the recommended antibiotics to prevent invasive pneumococcal disease (IPD),...
News

JAK2 inhibition could reduce risk of GVHD
- Author:
- HT Staff
Preclinical research suggests that targeting JAK2 can reduce the risk of graft-versus-host disease (GVHD) in transplant recipients. Researchers...
News

Child’s cancer diagnosis can affect mother’s income long-term
- Author:
- HT Staff
A study conducted in Sweden revealed that social benefits can ease financial burdens for parents of children recently diagnosed with cancer....
News

Product increases FIX levels in hemophilia B
- Author:
- HT Staff
MADRID—The recombinant factor IX (FIX) product CB 2679d/ISU304 can increase FIX levels in patients with severe hemophilia B, according to a phase...
News

Agent can decrease GI toxicity in MM patients
- Author:
- HT Staff
Results of a case-control study suggest a cytoprotective agent can reduce treatment-related gastrointestinal (GI) toxicity in patients with...